Midland Wealth Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Midland Wealth Advisors's ABBV Position: Q3 2026 in Review
Midland Wealth Advisors reduced its AbbVie (ABBV) stake by 7.6% in Q3 2026, selling an estimated $245K and leaving 11,706 shares worth $3.06M. The position accounts for 0.14% of the portfolio, ranked #36.
Midland Wealth Advisors first reported a position in ABBV in Q4 2023 and has held it in 12 quarters since. The position peaked at $3.52M in Q3 2025. 4,285 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Midland Wealth Advisors held 11,706 shares of AbbVie worth $3.06M as of Q3 2026.
- Midland Wealth Advisors sold 957 AbbVie shares in Q3 2026, an estimated $245K.
- AbbVie made up 0.14% of Midland Wealth Advisors's portfolio in Q3 2026, its #36 holding.
- Midland Wealth Advisors first reported a position in AbbVie in Q4 2023 and has held it in 12 quarters since.
- Midland Wealth Advisors's AbbVie position peaked at $3.52M in Q3 2025.
- 4,285 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Midland Wealth Advisors's 13F filing for Q3 2026, filed 26 Oct 2026.